| Literature DB >> 35878323 |
Cheng-Hung Lai1, Yu-Chan Ma2, Wei-Yau Shia1, Yu-Ling Hsieh1, Chao-Min Wang3.
Abstract
The microbial communities on the skin of dogs include several species of bacteria, which contribute to skin health and disease. Staphylococcus pseudintermedius, cultured at high frequency from the skin of dogs, is an opportunistic pathogen causing superficial pyoderma. Effective treatment against S. pseudintermedius infections is an important issue in veterinary medicine. However, multiple antibiotic-resistant mechanisms gradually developed by bacteria make treatment more challenging nowadays. Drug-resistant genes may have the chance to be transferred from infected dogs to other staphylococci in humans. The objective of this survey is to investigate the bacterial species that cause canine superficial pyoderma and characterize the antibiotic-resistant profiles and drug-resistant genes of isolated S. pseudintermedius. In addition, the possible risk factors causing S. pseudintermedius colonizing owners were also evaluated by a questionnaire survey. Sixty-five bacteria were isolated from dogs with superficial pyoderma, which included 47 S. pseudintermedius (72.3%), 12 other staphylococci (18.5%), 4 other Gram-positive bacteria (6.2%) and 2 Gram-negative bacteria (3.1%). Strains containing mecA and blaZ genes showed multiple-drug resistance characteristics. Dogs that received antimicrobial treatment within a recent month were at significantly higher risk of MRSP infections. Only five S. pseudintermedius strains (8.33%) were isolated from 60 samples of owners. Risk factor analysis indicated there was no significant association between S. pseudintermedius isolated from dogs and owners, but the "Keeping three or more dogs" and "Dogs can lick the owner's face" have high odds ratios of 3.503 and 5.712, respectively. MRSP isolates belonged to three different dru types, including dt11y (29.41%), dt11a (47.06%) and dt10cp (23.53%). In conclusion, the major pathogen of canine superficial pyoderma is found to be S. pseudintermedius in Taiwan, and isolates which are mecA- or blaZ-positive are generally more resistant to commonly used antibiotics. Although S. pseudintermedius isolated from the owners might be transferred from their dogs, definite risk factors should be examined in the future study.Entities:
Keywords: MRSP; Staphylococcus pseudintermedius; dru type; owners; risk factors; superficial pyoderma
Year: 2022 PMID: 35878323 PMCID: PMC9325117 DOI: 10.3390/vetsci9070306
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Figure 1Bacterial isolation and identification from dogs with superficial pyoderma (A) and their owner (B).
Antibiotics resistant profiles comparing between S. pseudintermedius and other Staphylococcus spp. from dogs.
| Antibiotics | Other | ||
|---|---|---|---|
| Gentamicin | 48.94% (23) | 16.67% (2) |
|
| Clindamycin | 40.43% (19) | 50.00% (6) | 0.549 |
| Ampicillin | 76.60% (36) | 83.30% (10) | 1.000 |
| Doxycycline | 55.32% (26) | 16.67% (2) |
|
| Augmentin * | 21.28% (10) | 16.67% (2) | 1.000 |
| Cephalexin | 25.53% (12) | 33.33% (4) | 0.718 |
| Penicillin G | 72.34% (34) | 83.33% (10) | 0.712 |
| Cephazolin | 25.53% (12) | 16.67% (2) | 0.712 |
| Enrofloxacin | 31.91% (15) | 8.33% (1) | 0.151 |
| Multi-drug resistant | 70.21% (33) | 83.33% (10) | 0.581 |
* Augmentin: amoxicillin + clavulanic acid.
Antibiotics resistant profiles comparing between mecA positive and negative of S. pseudintermedius from dogs.
| Antibiotics | |||
|---|---|---|---|
| Gentamicin | 81.25% (13) | 32.26% (10) |
|
| Clindamycin | 93.75% (15) | 12.90% (4) |
|
| Ampicillin | 100.00% (16) | 64.52% (20) |
|
| Doxycycline | 87.50% (14) | 38.71% (12) |
|
| Augmentin * | 62.50% (10) | 0.00% (0) |
|
| Cephalexin | 75.00% (12) | 0.00% (0) |
|
| Penicillin G | 100.00% (16) | 58.06% (18) |
|
| Cephazolin | 75.00% (12) | 0.00% (0) |
|
| Enrofloxacin | 87.50% (14) | 3.23% (1) |
|
| Oxacillin | 81.25% (13) | 12.90% (4) |
|
| Multi-drug resistant | 100.00% (16) | 54.84% (17) |
|
* Augmentin: amoxicillin + clavulanic acid.
Antibiotics resistant profiles comparing between blaZ positive and negative of S. pseudointermedius from dogs.
| Antibiotics | |||
|---|---|---|---|
| Gentamicin | 60.53% (23) | 0.00% (0) |
|
| Clindamycin | 50.00% (19) | 0.00% (0) |
|
| Ampicillin | 94.74% (36) | 0.00% (0) |
|
| Doxycycline | 68.42% (26) | 0.00% (0) |
|
| Augmentin * | 26.32% (10) | 0.00% (0) | 0.172 |
| Cephalexin | 31.58% (12) | 0.00% (0) | 0.087 |
| Penicillin G | 89.47% (34) | 0.00% (0) |
|
| Cephazolin | 31.58% (12) | 0.00% (0) | 0.087 |
| Enrofloxacin | 39.47% (15) | 0.00% (0) |
|
| Multi-drug resistant | 86.84% (33) | 0.00% (0) |
|
* Augmentin: amoxicillin + clavulanic acid.
Antibiotics resistant profiles and dru gene typing of S. pseudointermedius from dogs.
| Antibiotics | dt11a ( | dt11y ( | dt10cp ( | |
|---|---|---|---|---|
| Gentamicin | 87.5% (7) | 60.0% (3) | 100.0% (4) | 0.394 |
| Clindamycin | 87.5% (7) | 100.0% (5) | 100.0% (4) | 1.000 |
| Ampicillin | 100.0% (8) | 100.0% (5) | 100.0% (4) | - |
| Doxycycline | 87.5% (7) | 60.0% (3) | 100.0% (4) | 0.394 |
| Augmentin * | 50.0% (4) | 60.0% (3) | 100.0% (4) | 0.344 |
| Cephalexin | 62.5% (5) | 80.0% (4) | 100.0% (4) | 0.630 |
| Penicillin G | 100.0% (8) | 100.0% (5) | 100.0% (4) | - |
| Cephazolin | 62.5% (5) | 80.0% (4) | 100.0% (4) | 0.630 |
| Enrofloxacin | 100.0% (8) | 60.0% (3) | 100.0% (4) | 0.118 |
* Augmentin: amoxicillin + clavulanic acid.
Risk factors analysis of MRSP and MSSP from dogs.
| Risk Factors | MRSP from Dogs ( | MSSP from Dogs ( | OR | 95% Confidence Interval | |
|---|---|---|---|---|---|
| Owner works in medical institution | 12.5% (2) | 6.9% (2) | 1.93 | 0.245–15.185 | 0.608 |
| Dogs treated with antibiotics within a month | 75.0% (12) | 20.7% (6) | 11.5 | 2.711–48.777 |
|
Comparison of S. pseudintermedius isolated from dogs and their owners.
| Isolated Strains * | Antibiotics Resistant Profiles ** | ||
|---|---|---|---|
| C9 | + | + | CN, DA, AMP, DO, AMC, CL, OX, P, KZ, ENR |
| H9 | + | + | CN, DA, AMP, AMC, CL, OX, P, KZ, ENR |
| C35 | – | + | CN, AMP, DO, P |
| H35 | – | + | – |
| C41 | – | + | CN, AMP, P |
| H41 | – | + | AMP, P |
| C45 | – | + | CN, AMP, P |
| H45 | – | + | AMP, P |
| C48 | – | + | AMP, P |
| H48 | – | + | AMP, P |
* The name of isolated strains: C indicates isolated from canine and H is from human. The same strain number means the dog is kept by the same owner. ** AMC: amoxicillin + clavulanic acid, AMP: ampicillin, KZ: cephazolin, CL: cephalexin, DA: clindamycin, DO: doxycycline, ENR: enrofloxacin, CN: gentamycin, OX: oxacillin, P: penicillin.
Possible risk factors analysis for S. pseudintermedius isolated from owners.
| Risk Factors | Positive ( | Negative ( | OR | 95% Confidence Interval | |
|---|---|---|---|---|---|
| Keeping three or more dogs | 20.0% (1) | 10.9% (6) | 3.053 | 0.246–37.892 | 0.475 |
| Dogs are kept indoors | 100.0% (5) | 96.3% (53) | - | - | 1.000 |
| Dogs can rest on the sofa seat in the living room | 100.0% (5) | 72.7% (40) | - | - | 0.318 |
| Dogs can enter the owner’s bedroom | 80.0% (4) | 76.3% (42) | 1.089 | 0.108–10.980 | 1.000 |
| Dogs can rest in the owner’s bedroom for a long time | 80.0% (4) | 70.9% (39) | 1.641 | 0.170–15.841 | 1.000 |
| Dogs can move on the owner’s bed | 40.0% (2) | 47.2% (26) | 0.744 | 0.115–4.805 | 1.000 |
| Contact with dogs more than three times a day | 100.0% (5) | 92.7% (51) | - | - | 1.000 |
| Dogs can lick owner’s hands | 80.0% (4) | 70.9% (39) | 1.641 | 0.170–15.841 | 1.000 |
| Dogs can lick owner’s face | 80.0% (4) | 38.1% (21) | 5.712 | 0.732–44.556 | 0.150 |
| Dogs can take a bathe in owner’s bathroom | 60.0% (3) | 67.2% (37) | 0.548 | 0.071–4.216 | 1.000 |